PHVS

Conviction 99HealthcareScan · Tue, Sep 8, 2026

PHVS$37.83+7.32%

ResistanceSupportVol 14Insider sell

Vol MA14 904.73K

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Pharvaris N.V.Biotechnologywww.pharvaris.com ↗

Price37.83

Change+7.32%

Gap+15.12%

Rel volume7.85×

Avg volume859.2K

Avg $ vol31.34M

SMA 2035.89

SMA 5034.86

SMA 20029.60

Price vs 50+8.51%

Price vs 200+27.79%

MA stackbullish

50/200 cross—

Supertrendup · 33.75

RSI (14)62

MACD hist-0.03

MACD crossbear · 5d

Stoch %K / %D44 / 40

ADX (14)24

+DI / −DI37 / 10

RSI divergence—

MACD divergence—

ATR %+5.39%

ADR %5.25%

52w high37.83

52w low20.96

From 52w high+0.00%

Above 52w low+80.49%

New 52w highYes

SqueezeOn · 6d

Bollinger width11.50%

%B0.97

Donchian pos48.06%

Donchian high43.05

Donchian low33.00

AVWAP (52w high)39.49

vs AVWAP high-4.21%

AVWAP (52w low)30.93

vs AVWAP low+22.31%

OBV trendUp

Chaikin MF (20)-0.22

Today vs 20d7.85×

Avg vol (14d)904.73K

Avg vol (20d)859.2K

Avg $ vol (20d)31.34M

Market cap—

RS 3m (vs SPY)+8.96%

RS 6m (vs SPY)+21.50%

RS line new highNo

Trend template8/8

Technical rank89.6

1 week+9.30%

1 month+8.36%

3 months+19.75%

6 months+42.70%

1 year+64.12%

YTD+42.86%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target48.78

Target upside38.34%

Analyst ratingBuy

Institutional92.51%

Ent. value2.3B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out—

Employees129

ListedFri, Feb 5, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction99 / 100

Pattern quality—

Tech rank89.6 / 100

Group rank96 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance37.53

Support32.26

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in PHVS

All disclosures →

No recent disclosed trades by Congress in PHVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PHVS · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Modig Berndt Chief Executive Officer · Common Stock · 2026-08-14	Sell	2.29K	$80K	2026-08-14	2026-08-18
Modig Berndt Chief Executive Officer · Common Stock · 2026-07-13	Sell	2.29K	$80K	2026-07-13	2026-07-15
Schikan Johannes Gerardus Christiaan Petrus Director · Common Stock · 2026-06-29	Sell	2.4K	$84K	2026-06-29	2026-06-29
Lu Peng Chief Medical Officer · Common Stock · 2026-06-26	Exercise	14.7K	$38K	2026-06-26	2026-06-29
Lu Peng Chief Medical Officer · Common Stock · 2026-06-26	Sell	14.7K	$500K	2026-06-26	2026-06-29
Lu Peng Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-26	Exercise	14.7K	—	2026-06-26	2026-06-29
Lesage Anne Chief Early Development · Common Stock · 2026-06-25	Sell	2.3K	$81K	2026-06-25	2026-06-29
Lesage Anne Chief Early Development · Stock Option (Right to Buy) · 2026-06-25	Exercise	900	—	2026-06-25	2026-06-29
Lesage Anne Chief Early Development · Stock Option (Right to Buy) · 2026-06-25	Exercise	1.4K	—	2026-06-25	2026-06-29
Lu Peng Chief Medical Officer · Common Stock · 2026-06-25	Exercise	15K	$39K	2026-06-25	2026-06-29

SEC filings

EDGAR filings in PHVS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.